PROTHENA CORPORATION PUBLIC LIMITED COMPANY Public Float
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Public Float of $326.60 million as of 2025-06-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-27
- 2025-06-30: Entity Public Float $326.60M.
- 2024-06-30: Entity Public Float $870.30M.
- 2023-06-30: Entity Public Float $2.90B.
- 2022-06-30: Entity Public Float $955.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $326.60M 10-K · filed 2026-02-27 |
| 2024-06-30 | $870.30M 10-K · filed 2025-02-27 |
| 2023-06-30 | $2.90B 10-K · filed 2024-02-22 |
| 2022-06-30 | $955.80M 10-K · filed 2023-02-28 |
| 2021-06-30 | $1.73B 10-K · filed 2022-02-25 |
| 2020-06-30 | $318.75M 10-K · filed 2021-02-26 |
| 2019-06-28 | $328.80M 10-K · filed 2020-03-03 |
| 2018-06-30 | $406.70M 10-K · filed 2019-03-15 |
| 2017-06-30 | $2.10B 10-K · filed 2018-02-26 |
| 2016-06-30 | $1.20B 10-K · filed 2017-02-27 |
| 2015-06-30 | $1.65B 10-K · filed 2016-02-25 |
| 2014-06-30 | $600.70M 10-K · filed 2015-03-13 |
| 2013-06-28 | $187.10M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |